S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:CURR

Avenir Wellness Solutions (CURR) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free CURR Stock Alerts
$0.11
0.00 (0.00%)
(As of 08/9/2023)
Compare
Today's Range
$0.11
▼
$0.11
50-Day Range
$0.11
▼
$0.11
52-Week Range
$0.11
▼
$0.11
Volume
1,500 shs
Average Volume
68,634 shs
Market Capitalization
$8.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlines
CURR stock logo

About Avenir Wellness Solutions Stock (OTCMKTS:CURR)

Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was founded in 2011 and is headquartered in Sherman Oaks, California.

CURR Stock Price History

CURR Stock News Headlines

March 17, 2024 | finance.yahoo.com
Avenir Wellness Solutions, Inc. (AVRW)
December 29, 2023 | investing.com
Avenir Wellness Solutions Inc (AVRW)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
November 15, 2023 | theglobeandmail.com
Avenir Wellness Solutions Reports Third Quarter 2023 Results
September 11, 2023 | wsj.com
Avenir Wellness Solutions Inc.
August 8, 2023 | finanznachrichten.de
Avenir Wellness Solutions, Inc.: Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
August 8, 2023 | finance.yahoo.com
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
July 31, 2023 | benzinga.com
Avenir Wellness Solutions Stock Trading Higher On Q1 Revenue Growth Of 15.1% YoY
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
July 29, 2023 | investing.com
Avenir Wellness Solutions Inc (CURR)
June 27, 2023 | benzinga.com
New CEO Interview Discusses Surging Sales for DNA Complex and many other Corporate Topics of Interest; Avenir Wellness (Stock Symbol: CURR)
June 27, 2023 | health.usnews.com
Long-Term Solutions for How to Quit Vaping
April 26, 2023 | finanznachrichten.de
Avenir Wellness Solutions, Inc.: Avenir Wellness Solutions to Present at the Planet MicroCap Showcase - Live Webcast Available
April 26, 2023 | finance.yahoo.com
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
April 25, 2023 | finanznachrichten.de
Avenir Wellness Solutions, Inc.: Avenir Wellness Letter to Stockholders
April 7, 2023 | newsweek.com
Why Wellness Shouldn't Be a Trend
March 16, 2023 | finance.yahoo.com
Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
February 24, 2023 | finance.yahoo.com
New to The Street Announces the Televised Lineups for Shows 441, 442, and 443, Airings on Three Networks Will Begin on Saturday, February 25, 2023, 3:30 PM ET
February 13, 2023 | finance.yahoo.com
Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
February 9, 2023 | finance.yahoo.com
New to The Street TV Announces Episode #435 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Tonight, February 9, 2023, at 9:30 PM PT
February 6, 2023 | finance.yahoo.com
New to The Street Announces Episode #435, Interviews with Five Corporate Executives, Airing on the Fox Business Network, Tonight, Monday, February 6, 2023, at 10:30 PM PT
February 3, 2023 | finance.yahoo.com
New to The Street TV / Newsmax TV Announces Five Corporate Interviews Episode #434 Airing Saturday, February 4, 2023, 3:30 PM ET
January 19, 2023 | finanznachrichten.de
Avenir Wellness Solutions, Inc.: Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
January 19, 2023 | finance.yahoo.com
Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
January 14, 2023 | benzinga.com
CURE Pharmaceutical Hldg Stock (OTC:CURR), Quotes and News Summary
December 16, 2022 | finanznachrichten.de
CURE Pharmaceutical Holding Corp.: CURE Pharmaceutical Letter to Shareholders
December 15, 2022 | finance.yahoo.com
CURE Pharmaceutical Letter to Shareholders
See More Headlines
Receive CURR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avenir Wellness Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CURR
CUSIP
N/A
CIK
1643301
Web
www.curepharmaceutical.com
Phone
(805) 410-9962
Fax
805-487-7163
Employees
32
Year Founded
2011

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-25,510,000.00
Net Margins
-477.70%
Pretax Margin
-339.09%
Return on Equity
-621.61%
Return on Assets
-65.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.35
Quick Ratio
0.32

Sales & Book Value

Annual Sales
$4.90 million
Price / Sales
1.75
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-1.22

Miscellaneous

Outstanding Shares
78,168,000
Free Float
63,863,000
Market Cap
$8.60 million
Optionable
Not Optionable
Beta
0.31

Social Links

Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Nancy Duitch (Age 68)
    CEO & Director
    Comp: $254.49k
  • Mr. Joel M. Bennett (Age 61)
    CFO, Chief Accounting Officer, Sec. & Treasurer
    Comp: $206.71k
  • Ms. Patricia Hess
    Chief Operating Officer
  • Mr. Bhaumik Patel
    Director of New Technologies
  • Dr. Rahul Dixit M.D.
    Chief Medical Officer & Member of Medical Advisory Board

Key Competitors

View All Competitors

CURR Stock Analysis - Frequently Asked Questions

How have CURR shares performed in 2024?

Avenir Wellness Solutions' stock was trading at $0.11 on January 1st, 2024. Since then, CURR stock has increased by 0.0% and is now trading at $0.11.
View the best growth stocks for 2024 here.

How do I buy shares of Avenir Wellness Solutions?

Shares of CURR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CURR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media